Outsmarting complex diseases with more intelligent medicines" title="" class="btn" data-container="body" data-html="true" data-id="120761" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="Senti Biosciences"> 1,185 10,362
Activities
Technologies
Entity types
Location
2 Corporate Drive First Floor, South San Francisco, CA 94080, USA
South San Francisco
United States of America
Employees
Scale: 51-200
Estimated: 60
Engaged catalyst
4Added in Motherbase
3 years, 7 months agoOutsmarting complex diseases with more intelligent medicines
Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways previously inconceivable. To accomplish this mission, we are building a synthetic biology platform that could enable us to program next-generation cell and gene therapies with what we refer to as “gene circuits”. These gene circuits, which are created from novel and proprietary combinations of DNA sequences, are intended to reprogram cells with biological logic to sense inputs, compute decisions and respond to their cellular environments. We are designing gene circuits to improve the “intelligence” of cell and gene therapies in order to enhance their therapeutic effectiveness against a broad range of diseases that conventional medicines do not readily address.
For more information, please visit the Senti Bio website at https://www.sentibio.com.
Synthetic Biology, Gene Therapy, and Cell Therapy
Outsmarting Complex Diseases With More Intelligent Medicines
Catalyst | Type | Tweets | Articles | |
---|---|---|---|---|
![]() Kurma Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Kurma Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 31 Jan 2025 | | |
![]() AbbVie Pharmaceutical, Pharmaceutical Manufacturing | AbbVie Pharmaceutical, Pharmaceutical Manufacturing | Other 31 Jan 2025 | | |
![]() Morgan Stanley Finance, Bank | Morgan Stanley Finance, Bank | Other 8 Sep 2023 | | |
![]() Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 31 Jan 2025 | |